Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TMEM158 |
| Upstream (Parents) |
|---|
| (<<) ADAM12 → TMEM158 |
| (<<) CDCP1 → TMEM158 |
| (<<) CXCR7 → TMEM158 |
| (<<) DNM1L → TMEM158 |
| (<<) EMP1 → TMEM158 |
| (<<) FZD7 → TMEM158 |
| (<<) GSTZ1 → TMEM158 |
| (<<) HEY1 → TMEM158 |
| (<<) KLF4 → TMEM158 |
| (<<) MMP1 → TMEM158 |
| (<<) MMP19 → TMEM158 |
| (<<) MYO10 → TMEM158 |
| (<<) ORM1 → TMEM158 |
| (<<) PCK2 → TMEM158 |
| (<<) PLAU → TMEM158 |
| (<<) SLC20A1 → TMEM158 |
| (<<) SMAD2 → TMEM158 |
| (<<) TAF1A → TMEM158 |
| (<<) UPP1 → TMEM158 |
| Downstream (Children) |
|---|
| TMEM158 → ARAF (>>) |
| TMEM158 → ASTN2 (>>) |
| TMEM158 → BCL3 (>>) |
| TMEM158 → CYP27B1 (>>) |
| TMEM158 → IL1A (>>) |
| TMEM158 → MMP10 (>>) |
| TMEM158 → MMP3 (>>) |
| TMEM158 → NPC1 (>>) |
| TMEM158 → SMO (>>) |
